CAM
PRAX icon

Cormorant Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Cormorant Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214M Sell
640,000
-245,500
-28% -$77.7M 10.98% 1
2026
Q1 		$285M Sell
885,500
-64,500
-7% -$20M 14.33% 1
2025
Q4 		$280M Sell
950,000
-50,000
-5% -$9.31M 12.95% 1
2025
Q3 		$53M Sell
1,000,000
-625,000
-38% -$30.3M 3.66% 11
2025
Q2 		$68.3M Sell
1,625,000
-120,000
-7% -$4.57M 5.09% 4
2025
Q1 		$66.1M Buy
1,745,000
+51,781
+3% +$3.23M 4.97% 5
2024
Q4 		$130M Buy
1,693,219
+823,219
+95% +$59.6M 7.16% 2
2024
Q3 		$50.1M Buy
870,000
+185,000
+27% +$9.99M 2.65% 9
2024
Q2 		$28.3M Sell
685,000
-625,000
-48% -$29.5M 1.64% 19
2024
Q1 		$79.9M Buy
1,310,000
+676,655
+107% +$30.4M 3.51% 6
2023
Q4 		$14.1M Buy
633,345
+12
+0% +$216 0.67% 35
2023
Q3 		$16.2M Hold
633,333
– – 0.95% 27
2023
Q2 		$10.9M Buy
+633,333
New +$9.7M 0.61% 37
2022
Q2 		– Sell
-50,160
Closed -$7.68M – 85
2022
Q1 		$7.68M Hold
50,160
– – 0.59% 46
2021
Q4 		$14.8M Sell
50,160
-18,117
-27% -$5.31M 0.88% 32
2021
Q3 		$18.9M Buy
68,277
+1
+0% +$271 0.77% 37
2021
Q2 		$18.7M Sell
68,276
-3,334
-5% -$1.19M 0.64% 42
2021
Q1 		$35.2M Hold
71,610
– – 0.78% 34
2020
Q4 		$57.7M Buy
+71,610
New +$41.8M 1.37% 25

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Cormorant Asset Management's PRAX Position: Q2 2026 in Review

Cormorant Asset Management reduced its Praxis Precision Medicines (PRAX) stake by 28% in Q2 2026, selling an estimated $77.7M and leaving 640,000 shares worth $214M. The position accounts for 10.98% of the portfolio, ranked #1.

Cormorant Asset Management first reported a position in PRAX in Q4 2020 and has held it in 19 quarters since. The position peaked at $285M in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Cormorant Asset Management held 640,000 shares of Praxis Precision Medicines worth $214M as of Q2 2026.
  • Cormorant Asset Management sold 245,500 Praxis Precision Medicines shares in Q2 2026, an estimated $77.7M.
  • Praxis Precision Medicines made up 10.98% of Cormorant Asset Management's portfolio in Q2 2026, its #1 holding.
  • Cormorant Asset Management first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 19 quarters since.
  • Cormorant Asset Management's Praxis Precision Medicines position peaked at $285M in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Cormorant Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.